Research
Compare
Two to six companies, their latest annual figures side by side, from SEC filings.
CLDICalidi Biotherapeutics, Inc.
| Figure | CLDICalidi Biotherapeutics, Inc.FY2022 · Dec |
|---|---|
| Revenue | $45.00K |
| Revenue, yoy | — |
| Net income | $19.91M |
| Net income, yoy | +10.1% |
| Net margin | — |
| Free cash flow | — |
| FCF margin | — |
| EPS, diluted | $5.95 |
Add another company.
Annual · USD
No annual figures on file for this.
From SEC EDGARSame fiscal periods, as filed